Immuron Limited (IMRN) financial statements and ratios from SEC XBRL: revenue $7.29M (TTM), net margin -71.6%, revenue growth 48.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $7.29M |
| Net Margin | -71.6% |
| Revenue Growth (YoY) | 48.6% |
| EPS Growth (YoY) | -25.7% |
| Price / Book | 33.63 |
| Price / Sales | 49.58 |
| Sector P/E (Healthcare) | 21.7 |
IMRN overview · IMRN earnings · IMRN KPIs · IMRN investor relations · IMRN ownership · IMRN peers · IMRN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.